Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Avelas Biosciences Inc.
DescriptionIV fluorescent protease-activated peptide
Molecular Target
Mechanism of ActionDiagnostic; Imaging agent
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPhase I
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose lymph node metastases in breast cancer patients
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today